Opportunities exist for a Manager and Clinical Pharmacists inHematology, Oncology and Blood & Marrow Transplant/Cellular Therapeutics to join the Cancer Care Team at The University of Kansas Health System Cancer Center (TUKHS-CC).
Our team continues to increase its clinical presence in our NCI-Comprehensive Cancer Center and maintains a high level of rapport with physicians, mid-level providers and interdisciplinary partners on the patient care team.
The Pharmacy Operations Manager is responsible for the day-to-day operations in four cancer center pharmacies. This manager works closely with pharmacy technician leadership to ensure staffing coverage and workflows that support safe and efficient operations. The Pharmacy Operations Manager maintains strong interdisciplinary relationships and seamless communication within the Pharmacy Leadership Team. Responsibilities include process improvement, development of the team and regulatory compliance relating to pharmacy operations.
Clinical Pharmacists provide clinical services ranging from inpatient rounding to outpatient clinic and infusion center support in ambulatory cancer centers. The team also collaborates closely with Investigational Drug Services and the Pharmacy Informatics Beacon Team. Clinical Pharmacists enjoy a diverse practice but most settle into primary clinical areas of focus. Our team also provides a rich environment for professional development opportunities including precepting pharmacy students, PGY1 and PGY2 residents, as well staying involved in professional organizations. Current support provided for inpatient services include: Oncology, Hematology and Blood and Marrow Transplant (BMT) & Cellular Therapeutics. Current support provided for outpatient ambulatory clinics include: Acute leukemia, BMT/Cellular Therapeutics, Breast, Hematology multiple myeloma/lymphoma), Gastrointestinal (GI), Genitourinary (GU), Gynecology-Oncology, Head/Neck/Lung, Melanoma/Sarcoma
The pharmacy cancer care team is comprised of over 55 pharmacists with specialized training supporting 6 cancer sites throughout the Kansas City Metropolitan area and >1000-bed hospital in Kansas City. TUKHS-CC has been ranked for Cancer treatment in U.S. News & Worlds Reports for the past 7 years. Our investigational pharmacy team manages over 400 clinical trials throughout the health system and is comprised of 8 pharmacists servicing 3 locations.
It is an exciting time to begin a career at The University of Kansas Health System! This position offers a competitive salary and benefits package along with support for board certification. For more information about a career with our Pharmacy Cancer Care Team please contact Zahra Mahmoudjafari, Pharmacy Clinical Manager, at firstname.lastname@example.org.
The University of Kansas Health System is the region's premier academic medical center, providing a full range of care. The health system is affiliated with the University of Kansas Schools of Medicine, Nursing and Health Professions, and their various leading-edge research projects. Many health care organizations talk about a multidisciplinary approach to patient care. Only at an academic medical center like The University of Kansas Health System will you find the necessary level of knowledge and scientific inquiry to support that level of care, where specialists in different medical fields work together to make the right decisions for each patient.
Nationally ranked in nine adult medical and surgical specialties according to U.S. News & World Report's Best Hospital Rankings, placing the hospital within the top 1% of the country. U.S. News also recognized The University of Kansas Hospital as the “Best Hospital in Kansas City” for the ninth consecutive year and “Best Hospital in Kansas” for the seventh consecutive year.
In November 2017, the health system opened an additional 11 floor hospital tower north of the main campus adding 124 beds and 7 OR suites bringing the total lic...ensed bed number to over 850. The new Cambridge Tower A has allowed for expansion of services including specialized surgeries, oncology, neurosciences and otolaryngology. The strategic plan for the next 30 years includes 3 additional towers for future growth.